IVERIC bio Inc Watch

EX-10.3

from 10-Q 30 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions

12/34/56

EX-10.2

from 10-Q 2 pages Amendment No. 5 to Non-Employee Director Compensation Policy of IVERIC Bio, Inc

12/34/56

EX-10.1

from 10-Q 1 page Amendment No. 6 to 2019 Inducement Stock Incentive Plan Amendment No. 6 to 2019 Inducement Stock Incentive Plan of IVERIC Bio, Inc

12/34/56

EX-10.17

from 10-K 1 page Amendment No. 6 to 2019 Inducement Stock Incentive Plan Amendment No. 6 to 2019 Inducement Stock Incentive Plan of IVERIC Bio, Inc

12/34/56

EX-10.10

from 10-K 1 page Amendment No. 1 to 2016 Employee Stock Purchase Plan of IVERIC Bio, Inc

12/34/56

EX-10.1

from 10-Q 3 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Amendment No. 2 to Exclusive License Agreement With Know-How

12/34/56

EX-10.3

from 10-Q 1 page Amendment No. 5 to 2019 Inducement Stock Incentive Plan Amendment No. 5 to 2019 Inducement Stock Incentive Plan of IVERIC Bio, Inc

12/34/56

EX-10.2

from 10-Q 63 pages Material contract

12/34/56

EX-10.1

from 10-Q 43 pages Material contract

12/34/56

EX-10.2

from 10-Q 2 pages Amendment No. 4 to Non-Employee Director Compensation Policy of IVERIC Bio, Inc

12/34/56

EX-10.36

from 10-K 6 pages November 10, 2021 the Board of Directors of IVERIC Bio, Inc. (The “Company”) Has Provided for the Following Severance Benefits to Be Provided to You in the Event of Your Termination of Employment With the Company, on the Terms and Conditions Set Forth Herein. 1. Severance

12/34/56

EX-10.35

from 10-K 6 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. November 19, 2021

12/34/56

EX-10.34

from 10-K 7 pages June 16, 2021 IVERIC Bio, Inc. (The “Company”) Will Provide for the Following Severance Benefits for You in the Event of Your Termination of Employment With the Company, on the Terms and Conditions Set Forth Herein. 1. Severance

12/34/56

EX-10.33

from 10-K 5 pages June 16, 2021 [**]

12/34/56

EX-10.19

from 10-K 3 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. First Amendment to License Agreement No. A18025

12/34/56

EX-10.4

from 10-Q 7 pages The Board of Directors (The “Board”) of IVERIC Bio, Inc. (The “Company”) Has Provided for the Following Severance Benefits to Be Provided to You in the Event of Your Termination of Employment With the Company, on the Terms and Conditions Set Forth Herein. This Letter Agreement Dated as of the Date First Set Forth Above Amends and Restates in Its Entirety That Certain Severance Benefits Letter Agreement Between You and the Company Dated January 4, 2016. 1. Severance

12/34/56

EX-10.3

from 10-Q 1 page Amendment No. 3 to 2019 Inducement Stock Incentive Plan of IVERIC Bio, Inc

12/34/56

EX-10.2

from 10-Q 7 pages June 16, 2021 IVERIC Bio, Inc. (The “Company”) Will Provide for the Following Severance Benefits for You in the Event of Your Termination of Employment With the Company, on the Terms and Conditions Set Forth Herein. 1. Severance

12/34/56

EX-10.1

from 10-Q 5 pages Material contract

12/34/56

EX-10.2

from 10-Q 2 pages Amendment No. 2 to Master Sponsored Research Agreement

12/34/56